Cardiovascular risk factors in children and adolescents with type 1 diabetes mellitus: the role of insulin resistance and associated genetic variants

被引:3
作者
Maguolo, Alice [1 ]
Rioda, Marco [1 ]
Zusi, Chiara [1 ,2 ]
Emiliani, Federica [1 ]
Olivieri, Francesca [1 ]
Piona, Claudia [1 ]
Marigliano, Marco [1 ]
Orsi, Silvia [1 ]
Morandi, Anita [1 ]
Maffeis, Claudio [1 ]
机构
[1] Univ Verona, Dept Surg Dent Pediat & Gynecol, Sect Pediat Diabet & Metab, Verona, Italy
[2] Univ Hosp Verona, Pediat Diabet & Metab Disorders Unit, Piazzale A Stefani 1, I-37126 Verona, Italy
来源
HORMONE RESEARCH IN PAEDIATRICS | 2023年 / 96卷 / 03期
关键词
METABOLIC SYNDROME; GLYCEMIC CONTROL; LIFE EXPECTANCY; HEIGHT RATIO; POLYMORPHISM; DISEASE; COMPLICATIONS; DYSLIPIDEMIA; METAANALYSIS; SENSITIVITY;
D O I
10.1159/000527520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Type 1 diabetes (T1D) is associated with increased risk of cardiovascular disease. Insulin resistance is an important cardiovascular risk factor (CVRF), also in subjects with T1D, but the influence of the genetic predisposition of insulin resistance on cardiovascular risk is still unknown in T1D. We aimed to determine whether a genetic score composed of six variants, previously associated to insulin resistance and type 2 diabetes (T2D) risk, associates with insulin sensitivity and known CVRFs in children and adolescents with T1D.Materials and Methods: 330 children and adolescents (174 males; mean age 15.7 +/- 3.5 years) with T1D were genotyped for the following genetic variants: rs1801278 (IRS1), rs1044498 (ENPP1), rs2295490 (TRIB3), rs1801282 (PPARG), rs780094 (GCKR), and rs35767 (IGF1). An additive genetic risk score (GRS) and cardiovascular risk score (CVRS) were calculated. Anthropometric, glycemic control, insulin sensitivity, blood pressure, and biochemical parameters were assessed. Multivariate regression between evaluated phenotypes and GRS were performed. Results: We found a significant association between the GRS and estimated insulin sensitivity [beta=-0.027 (-0.040 to -0.013), R2=0.86, p=<0.001], diastolic blood pressure [beta=0.68 (0.08-1.27), R2=0.20, p=0.026], triglycerides [beta=4.26 (1.74-6.77), R2=0.13, p=0.001], waist to height ratio [beta=0.003 (0.001-0.006), R2=0.75, p=0.010], non-HDL-cholesterol [beta=3.63 (1.39-5.87), R2=0.12, p=0.002], and CVRS [beta=0.063 (0.008-0.118), R2=0.19, p=0.025], independent of age, sex, BMI, pubertal stage, diabetes duration, HbA1c, type of treatment and total insulin requirement. The addition of the GRS to established clinical risk factors significantly improved the discriminatory capability of the regression model for predicting subjects with more CVRFs (C-statistic 0.89 [95%CI 0.84-0.95] vs. 0.83 [0.73-0.93]; p = 0.037).Conclusions: Insulin resistance and T2D risk-associated genetic variants influence insulin sensitivity and known cardiovascular risk factors in children and adolescents with T1D.
引用
收藏
页码:306 / 315
页数:10
相关论文
共 52 条
[1]   Dietary patterns are associated with various vascular health markers and complications in type 1 diabetes [J].
Ahola, Aila J. ;
Freese, Riitta ;
Makimattila, Sari ;
Forsblom, Carol ;
Groop, Per-Henrik .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (06) :1144-1150
[3]   Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance [J].
Bacci, Simonetta ;
Prudente, Sabrina ;
Copetti, Massimiliano ;
Spoto, Belinda ;
Rizza, Stefano ;
Baratta, Roberto ;
Di Pietro, Natalia ;
Morini, Eleonora ;
Di Paola, Rosa ;
Testa, Alessandra ;
Mallamaci, Francesca ;
Tripepi, Giovanni ;
Zhang, Yuan-Yuan ;
Mercuri, Luana ;
Di Silvestre, Sara ;
Lauro, Renato ;
Malatino, Lorenzo ;
Consoli, Agostino ;
Pellegrini, Fabio ;
Pandolfi, Assunta ;
Frittitta, Lucia ;
Zoccali, Carmine ;
Federici, Massimo ;
Doria, Alessandro ;
Trischitta, Vincenzo .
ATHEROSCLEROSIS, 2013, 226 (01) :140-145
[4]   Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC study [J].
Bebu, Ionut ;
Braffett, Barbara H. ;
Orchard, Trevor J. ;
Lorenzi, Gayle M. ;
Nathan, David M. ;
Herman, William H. ;
Lachin, John M. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 171
[5]   The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes - Results from Metascreen, a multicenter diabetes clinic-based survey [J].
Bonadonna, Riccarcdo C. ;
Cucinotta, Domenico ;
Fedele, Domenico ;
Riccardi, Gabriele ;
Tiengo, Antonio .
DIABETES CARE, 2006, 29 (12) :2701-2707
[6]   Type 1 diabetes, metabolic syndrome and cardiovascular risk [J].
Chillaron, Juan J. ;
Flores Le-Roux, Juana A. ;
Benaiges, David ;
Pedro-Botet, Juan .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (02) :181-187
[7]   Atherogenic dyslipidemia in patients with type 1 diabetes mellitus [J].
Chillaron, Juan J. ;
Sales, Maria P. ;
Flores Le-Roux, Juana A. ;
Castells, Ignasi ;
Benaiges, David ;
Sagarra, Enric ;
Pedro-Botet, Juan .
MEDICINA CLINICA, 2013, 141 (11) :465-470
[8]   Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? [J].
Cleland, S. J. ;
Fisher, B. M. ;
Colhoun, H. M. ;
Sattar, N. ;
Petrie, J. R. .
DIABETOLOGIA, 2013, 56 (07) :1462-1470
[9]   So many correlated tests, so little time!: Rapid adjustment of P values for multiple correlated tests [J].
Conneely, Karen N. ;
Boehnke, Michael .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (06) :1158-1168
[10]   Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study [J].
Dabelea, D. ;
D'Agostino, R. B., Jr. ;
Mason, C. C. ;
West, N. ;
Hamman, R. F. ;
Mayer-Davis, E. J. ;
Maahs, D. ;
Klingensmith, G. ;
Knowler, W. C. ;
Nadeau, K. .
DIABETOLOGIA, 2011, 54 (01) :78-86